Smith & Nephew SNATS (NYSE:SNN – Get Free Report) was upgraded by investment analysts at Kepler Capital Markets to a “strong-buy” rating in a research report issued to clients and investors on Monday,Zacks.com reports.
A number of other analysts have also recently weighed in on the stock. Royal Bank Of Canada reissued an “outperform” rating on shares of Smith & Nephew SNATS in a report on Monday, October 20th. Sanford C. Bernstein set a $37.50 price objective on shares of Smith & Nephew SNATS and gave the company a “market perform” rating in a research report on Tuesday, October 14th. Canaccord Genuity Group cut their target price on shares of Smith & Nephew SNATS from $36.00 to $34.00 and set a “hold” rating on the stock in a report on Tuesday, November 11th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Smith & Nephew SNATS in a report on Wednesday, October 8th. Finally, Wall Street Zen cut Smith & Nephew SNATS from a “strong-buy” rating to a “buy” rating in a research report on Friday, October 3rd. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, Smith & Nephew SNATS presently has an average rating of “Hold” and a consensus target price of $35.75.
Read Our Latest Stock Analysis on Smith & Nephew SNATS
Smith & Nephew SNATS Stock Down 0.0%
Institutional Investors Weigh In On Smith & Nephew SNATS
Large investors have recently made changes to their positions in the company. Richards Merrill & Peterson Inc. grew its holdings in Smith & Nephew SNATS by 500.0% in the 1st quarter. Richards Merrill & Peterson Inc. now owns 1,200 shares of the medical equipment provider’s stock worth $34,000 after buying an additional 1,000 shares in the last quarter. AlphaCore Capital LLC bought a new stake in Smith & Nephew SNATS during the 2nd quarter valued at $44,000. Northwestern Mutual Wealth Management Co. grew its stake in shares of Smith & Nephew SNATS by 105.8% in the third quarter. Northwestern Mutual Wealth Management Co. now owns 1,385 shares of the medical equipment provider’s stock worth $50,000 after purchasing an additional 712 shares in the last quarter. Huntington National Bank grew its stake in shares of Smith & Nephew SNATS by 1,837.0% in the third quarter. Huntington National Bank now owns 1,414 shares of the medical equipment provider’s stock worth $51,000 after purchasing an additional 1,341 shares in the last quarter. Finally, Banque Transatlantique SA acquired a new position in shares of Smith & Nephew SNATS during the first quarter valued at $52,000. Institutional investors and hedge funds own 25.64% of the company’s stock.
Smith & Nephew SNATS Company Profile
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.
Read More
- Five stocks we like better than Smith & Nephew SNATS
- What Does a Stock Split Mean?
- Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum
- What is the MACD Indicator and How to Use it in Your Trading
- What’s on the Thanksgiving Table? A Stock Pick for Every Course
- Stock Market Upgrades: What Are They?
- Why Home Depot’s Pain Could Be a Long-Term Investor’s Gain
Receive News & Ratings for Smith & Nephew SNATS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew SNATS and related companies with MarketBeat.com's FREE daily email newsletter.
